2009
January
Cover Story
Disruptive Innovations That Will Change Your Life in Health Care
Don’t Get Trapped By PBMs’ Rebate Labeling Games
Multifaceted Diabetes Program Pays Off for HealthPartners
Health Plans: Disrupt and Prosper
Q&A with Clayton Christensen, DBA
February
Cover Story
It’s No Longer Just Members Who Are Suing Health Plans
Are Health Plans Responding to Primary Care Shortage?
Health Plans Join Up for the Genomics Revolution
What Does the Future Hold for Disease Management?
Today’s Technology Can Facilitate Collaborative Network Management
Peer-Reviewed
Effect of Drug Therapy on HEDIS Measurements of HbA1c Control In Diabetes Patients
March
Cover Story
Providers Enlisted To Curtail Waste
Cigna’s CDHP Study Bolsters Prevention
Plans and Physicians in Hawaii Experiment With Online ‘Visits’
Modern Cardiovascular Programs Cut Costs, Inpatient Days, and Deaths
Q&A
A Conversation With Dee W. Edington, PhD: Changing Culture To Support Wellness
April
Cover Story
Comparative Effectiveness: An Idea Whose Time Has Finally Come
Health Plans and Providers Struggle to Fix Payment System
Molecular Diagnostic Testing Presents $5 Billion Conundrum
Peer-Reviewed
Barriers to Breast Cancer Screening In a Managed Care Population
Q&A
May
Cover Story
If You Think It’s Bad Now, Plans Could See Worse
Managing the Cost of Diagnosis
How To Develop Coverage Policies For Molecular Diagnostics
The Federal Stimulus Package: What’s in It for You?
When Should Insurers Cover Off-Label Drug Usage?
Q&A
June
July
Cover Story
How to Save a Bundle on Hospital Readmissions
Want to Change Patients’ Behavior? Look to the Internet
Is Your Online Formulary Guide Ready for Uncle Sam’s Scrutiny?
Peer-Reviewed
Effect of Patient Medication Cost Share on Adherence and Glycemic Control
Q&A
A Conversation With Thomas E. Getzen, PhD: How Much Are We Willing to Spend?
August
Cover Story
Value-Based Insurance Design: Spend a Little More On Selected Patients For Payoff Down the Line
Inventive Approaches Curtail Imaging Costs
Health Care Reform Push Pits States Against Feds
Use a Value-Based Strategy for Biotech Medications
Control Specialty Drug Cost By Making Your PBM Helpful
Q&A
A Conversation with the Dartmouth Atlas Project’s Elliott Fisher, MD, MPH
September
October
November
Paul Lendner ist ein praktizierender Experte im Bereich Gesundheit, Medizin und Fitness. Er schreibt bereits seit über 5 Jahren für das Managed Care Mag. Mit seinen Artikeln, die einen einzigartigen Expertenstatus nachweisen, liefert er unseren Lesern nicht nur Mehrwert, sondern auch Hilfestellung bei ihren Problemen.